BDNF and obesity due to melanocortin 4 receptor deficiency: We have developed a molecular therapy and demonstrated the efficacy and safety of hypothalamic BDNF gene therapy in diet-induced and genetic models of obesity as well as aging mice of normal weight (93–96).